|
Apr 5
|
2 Under-the-Radar Biotech Stocks to Buy in 2023
|
|
Apr 4
|
Vertex Is 1 Step Closer to Bringing a New Blockbuster to Market. Time to Buy?
|
|
Apr 4
|
CRISPR (CRSP) & Vertex Complete BLA Submission for Exa-Cel
|
|
Apr 4
|
Vertex Pharmaceuticals Stock Sees Composite Rating Edge Up To 96
|
|
Apr 3
|
Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know
|
|
Apr 3
|
Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
|
|
Apr 2
|
Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Trading At A 29% Discount?
|
|
Apr 2
|
A Nasdaq Bull Market Could Begin in April: 3 Top Stocks to Buy Now
|
|
Apr 2
|
5 Top Stocks for April
|
|
Apr 1
|
Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics
|
|
Mar 31
|
This Top Growth Stock Is Targeting a Multi-Billion-Dollar Market. Here's What It Means for Investors
|
|
Mar 31
|
Have $2,000? 2 Exceptional Stocks to Buy In a Bear Market
|